Budget Process
Analysis: CT hospital finances during COVID’s first year
Download the report Download the extracted data In 2020, Connecticut hospitals’ revenues exceeded expenses by 2.61% or $325 million. Hospitals averaged 1.9% of expenses in uncompensated care, less than the US average. Top hospital executives averaged $2.6 million in total compensation. Hospitals paid $1.3 billion in fees to corporate parent health systems. Large health systems…
Read MorePolicy options to control healthcare prices and protect from private equity
Healthcare service prices are the main driver of Connecticut’s rising health insurance premiums. The consolidation of hospitals and providers into large health systems has stifled competition, allowing prices to rise unchecked. Other states have taken action to protect competition in consolidated markets and it’s working. Connecticut needs to act. Private equity funds are buying critical…
Read MoreCTNJ OP-ED | Connecticut’s Healthcare Market Regulation is Broken
Connecticut’s healthcare markets are consolidating at a serious clip and it’s endangering access to care and driving up healthcare prices that make care unaffordable. Unfortunately, the state agency that is supposed to keep Connecticut’s healthcare market competitive isn’t acting. They have the tools – Connecticut has among the most protective laws in the nation. But…
Read MoreNew Cost Cap industry-driven committee gets going
Members of the Office of Health Strategy’s (OHS) latest committee to drive down the growth in Connecticut’s healthcare spending moved past their initial reluctance to engage in their November and December meetings. OHS expects the provider and insurer-dominated committee to agree on ways to reduce their own costs/profits. Hopefully, they do not also use the…
Read MoreFAQs on OHS’s Primary Care Roadmap
Download the FAQs here Connecticut’s Office of Health Strategy has developed a Primary Care Roadmap to support primary care in Connecticut. OHS is accepting public comment on the draft Roadmap until the close of business Friday, January 14th. To send comments, email Tina.Hyde@ct.gov and put “Primary Care Roadmap” in the subject line. You should get…
Read MoreSign up for daily tips on the Art and Craft of Advocacy
You want to make a difference, but advocacy can be confusing, frustrating, and time-consuming. We can help. Sign up for Today’s Advocacy Tool – a month of inspiration, tips, and practical tools. Every weekday for a month, we’ll send an email with insight, best practices, and lessons we’ve learned from the updated CT Health Advocacy…
Read MoreICER report on fair access to drugs prompts six insurers to change coverage policies
A powerful new scorecard from the Institute for Clinical and Economic Review (ICER) assessing 15 of the largest US formularies for barriers to accessing 28 fairly-priced drugs found generally good policies for clinical standards (96% are fair), step therapy (99%), and prescriber restrictions (100%). However, the report found poor policies for cost sharing tiers (77%)…
Read MoreOHS primary care committee sharply critical of agency’s plan
In this month’s meeting of the Office of Health Strategy’s Primary Care Subgroup, patient and consumer advocates joined insurers raising very strong concerns about OHS’s plans and capacity to implement the agency’s plan for primary care in Connecticut. OHS plans to double the share of Connecticut’s healthcare spending on primary care while tightly restricting growth…
Read MoreLast year unjustified price increases for nine drugs cost US healthcare $1.67 billion, Humira accounted for $1.4 billion
According to this year’s report, last year the US health system spent an extra $1.67 billion on price increases for nine drugs that were not supported by clinical evidence. Humira led this year’s list at $1.4 billion, accounting for 84% of US unjustified drug price increases in 2020. Humira aside, the more modest price increases…
Read MoreCTNJ: OP-ED | Legislators Hear How RI Saved 2 Hospitals From Private Equity, Other Solutions to High Insurance Premiums
On Friday, in a forum sponsored by state Rep. Kerry Wood, six national and local experts gave legislators specific policy tools to help with health care market consolidation and rising drug prices that are driving up health insurance premiums. Legislators also got specific tools used by Rhode Island to avoid private equity abuses experienced in…
Read More